Professor of Medicine,Co-Director, Digestive Diseases Center, University of Chicago
Takeda + UChicago
Takeda Pharmaceuticals, along with Dr. David Rubin and his colleagues at the University of Chicago, are leveraging Litmus Health in a 500 person study conducted over three years that is already producing exciting, publishable results.
We’re gathering data from smartphones, ePROs, and Fitbits to better understand the relationship between sleep, activity and flares in Crohn’s and Colitis patients. Our ultimate goal is to use the models to accurately predict outcomes.